Corporate Power — Breaking Up Monopolies, Rebuilding Competition

Corporate concentration has reached historic levels. Four meatpackers control 85% of US beef slaughter. Three PBMs process ~80% of all prescriptions. 97% of metro health insurance markets are 'highly concentrated.' The Big Four airlines control 74% of US seat capacity. The US bank count collapsed 72% since 1984 — from 14,496 to 4,027. JPMorgan Chase alone now holds $3.64 trillion in assets.

Federal antitrust enforcement has become structural theater. In August 2024, a federal judge declared Google a monopolist in search. In April 2025, a second ruling found Google illegally monopolized ad tech. Yet despite two judicial monopoly findings, the enforcement pathway remains broken: consent decrees expire, behavioral remedies reverse, and structural remedies — divestitures and breakups — remain the exception, not the default for proven monopolists.

The 'kill zone' effect drops venture capital investment 6× in markets after major tech acquisitions, directly suppressing startup formation. Hospital mergers produce 6–65% price increases with no documented quality improvement. Corporate markups surged from 18% above cost in 1980 to 67% above cost by 2016. Concentration is not efficient — it is efficient at extracting rents.

The CEO-to-worker pay ratio went from 21:1 in 1965 to 281:1 in 2024. S&P 500 stock buybacks hit a record $942.5 billion in 2024 — capital that could have funded wages, R&D, or investment, instead returned to shareholders. Business dynamism, startup formation, and local journalism have all declined in direct proportion to rising concentration.

For workers, non-competes currently restrict 30–60 million Americans from changing jobs or starting competing businesses. The FTC projects a federal ban would generate $488 billion in wage gains over a decade, create 8,500+ new businesses annually, and increase patenting activity by 14%+. Codetermination at 2,000+ employee firms gives workers half the supervisory board seats. The CEO pay deduction cap (50:1 CEO-to-median ratio) stops the public subsidy for extreme inequality.

For consumers, hospital merger prices drop by 6–65% without quality loss. The algorithmic price-fixing ban on rent, healthcare, and airline fares brings prices closer to competitive levels. Antitrust structural remedies prevent the next generation of anticompetitive acquisitions. Broadband reaches 42 million Americans currently stuck with one provider; the $50B fund prioritizes municipal and cooperative networks, delivering the 4.42:1 ROI Chattanooga proved possible.

For small businesses and entrepreneurs, the 'kill zone' effect disappears when killer acquisitions are presumptively blocked. Merger presumptions in concentrated markets stop big companies from acquiring nascent competitors before they scale. Farm consolidation stops; seed market concentration is capped at 25%; the Big Four meatpackers are broken up. Independent farmers and small tech companies can compete again.

For innovation, codetermination does not suppress innovation — German manufacturers competing globally prove it. VC investment no longer funnels through acquisition-for-kill channels; capital flows to companies scaling competitive products, not acquisition targets being eliminated. Patent creation increases 14%+ post-non-compete ban. Competition drives innovation; monopoly drives rent extraction.